Vanguard Group Inc. decreased its stake in HCA Healthcare, Inc. by 3.8% in Q3, selling over half a million shares, though it still held 6.53% of the company. Despite Vanguard’s reduction, analysts maintain a “Moderate Buy” consensus with a $523.27 price target. HCA Healthcare reported strong Q4 earnings, surpassing expectations, and increased its quarterly dividend.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Vanguard Group Inc. Reduces Stock Holdings in HCA Healthcare, Inc. $HCA
Vanguard Group Inc. decreased its stake in HCA Healthcare, Inc. by 3.8% in Q3, selling over half a million shares, though it still held 6.53% of the company. Despite Vanguard’s reduction, analysts maintain a “Moderate Buy” consensus with a $523.27 price target. HCA Healthcare reported strong Q4 earnings, surpassing expectations, and increased its quarterly dividend.